American Association of Clinical Endocrinology Communities Middle East & North Africa 2025

Description

+ Include: 56 videos + 56 file sub vtt + 54 pdfs, size: 23.46 GB
+ Target Audience: endocrinologists and primary care physicians
+ Sample video: contact me for sample video
+ Information:
1. Overview
The American Association of Clinical Endocrinology Communities Middle East & North Africa 2025 program provides a comprehensive review of the latest advancements in endocrinology. It covers critical updates in diabetes management technologies, obesity pharmacotherapy, thyroid cancer, menopause, and bone health, with special clinical considerations for regional practices such as managing patients during Ramadan.
The three-day event provided a platform for regional and international endocrinology leaders to collaborate and discuss advancements in diabetes, thyroid, bone, pituitary, adrenal, and metabolic health. It featured over 50 educational sessions and hands-on workshops tailored to the unique clinical challenges of the MENA region.
Course Date: November 21–23, 2025, at the InterContinental Dubai Festival City, United Arab Emirates
2. Learning Objectives
By the end of the meeting, you will be able to:

Demonstrate the understanding of a multidisciplinary approach, including lifestyle and nutrition in the effective management of metabolic diseases.
Gain insight and skills in implementation of self-management tools, new medications, AI and technology for improved outcomes in Diabetes.
Demonstrate appreciation and understanding of bone mineral disorders.
Explore the latest clinical guidelines for thyroid nodules and cancer, and engage in case-based learning of complex thyroid issues.
Review and apply evidence-based strategies for assessment and management of pituitary and adrenal conditions.
Integrate multidisciplinary approaches for improved care and treatment of endocrine disorders.
Evaluate, understand, and manage women’s health and menopause.

3. Target Audience

Best for endocrinologists and primary care physicians who want updates on diabetes management, obesity therapies, and thyroid disorders.

4. Topics

Closing Remarks

IDS1.A.1 CGM Use in People With and Without Diabetes

IDS1.A.2 SGLT2i Use in Type 1 DM

IDS1.A.3 GLP1 use in T1DM

IDS1.B.1 Menopause Hormone Therapy 101

IDS1.B.2 Mood, Sleep and Cognitive Function in Menopause

IDS1.B.3 Menopause and Cardiometabolic Risk

IDS1.C.1 Molecular Basis of Thyroid Cancer and its Translational Implications

IDS1.C.2 What’s New in Medullary Thyroid Cancer

IDS1.C.3 Contemporary Management of Graves’ Disease

IDS2.A.1 Diabetes and Ramadan An Update

IDS2.A.2 Thyroid and Ramadan In Health and Disease

IDS2.A.3 Adrenal Replacement in Ramadan

IDS2.B.1 Obesity Management in Adolescent

IDS2.B.2 From Fat Storage to Fat Burning Exploring the Role of Fasting in Obesity Treatment

IDS2.B.3 Approaching Weight Management in Women of Childbearing Age

IDS2.C.1 Smoking and Bone Health

IDS2.C.2 Osteoporosis in Men

IDS2.C.3 Bone Health in Cancer Patients

IDS2.D.1 Diabetes Management in the Older Adult

IDS2.D.2 Obesity Management in the Elderly

IDS2.D.3 When to Treat and When Not to Treat for Thyroid Disease in Geriatrics

IDS3.A.1 Mild Autonomous Cortisol Secretion MACS

IDS3.A.2 Adrenocortical Cancer New Advances

IDS3.A.3 Regional Barriers to Diagnosis and Management of Adrenal Insufficiency

IDS3.B.1 Obesity Management in Persons with Special Needs

IDS3.B.2 Metabolic and Bariatric Management in Pediatrics

IDS3.B.3 Turners Syndrome

MTE1.A What’s New in the Approach and Management of Pheochromocytoma Paraganglioma

MTE1.B Pituitary Tumors, Biology and Clinical Classification

MTE1.C Treatment of Osteoporosis in the Oldest Old

MTE2.A Prevention and Cure, Current and Future for Type 1 Diabetes

MTE2.B Management of Kidney Disease in Diabetes – An Update

MTE2.C Endocrine Practice in Resource – Limited Settings

MTE3.A Screening & Management of Metabolic Liver Disease in Endocrine Clinics

MTE3.B What is in the Pipeline for Diabetes and Obesity Management

MTE3.C Islet Cell Transplant, Innovations in Type 1 Diabetes Management

MTE3.D Remission of T2D Through Diet – Is it Real

MTE4.ASurgicalHypoparathyroidism

MTE4.B Thyroid Autoimmunity and Cardiovascular Risk Beyond Hypothyroidism

MTE4.C Beyond BMI The Role of Body Composition Assessment in Obesity Pharmacotherapy

MTE4.D Testosterone Replacement – Indications and Challenges

MTE5.A Primary Aldosteronism

MTE5.B What is the Role for Lifestyle Support in the New Era of Medical Treatment for Obesity

MTE5.C Parathyroid in Pregnancy

PL1. Acromegaly, Diagnosis, Management and Anomalies

PL2. Understanding Sexual Dysfunction in Women with Obesity and Diabetes

PL3. Updated Thyroid Nodule and Cancer Guidelines, An Endocrine Surgeon’s Perspective

PL4. Indications for SGLT2I and Incretin-Based Therapy Beyond Diabetes Overview and Future Outlook

PL5. Congenital Adrenal Hyperplasia

PL6. Diagnosis and Management of Hypoparathyroidism

PL7. Breaking the Cycle From Fat Cells and Gut to the Mind in Weight Regain

Roundtable Discussion – Ali Alzahrani

Roundtable Discussion – Samer El-Kaissi

Roundtable Discussion – Tamer Elsherbiny

Welcome and Opening Ceremony